Mizuho Downgrades Select Medical Hldgs to Neutral, Lowers Price Target to $16.5

Mizuho analyst Ann Hynes downgrades Select Medical Hldgs (NYSE:SEM) from Outperform to Neutral and lowers the price target from $17 to $16.5.